
What We’re Reading: ADHD Medication Mix-Up; Surge in ACOs; Mifepristone Restrictions
Attention-deficit/hyperactivity disorder (ADHD) medication packets are found with incorrect pills; CMS data reveal record numbers of providers and beneficiaries participating in accountable care organizations (ACOs); Supreme Court will hear arguments over FDA regulations on abortion medication in March.
ADHD Medication Pulled From Shelves Amid Pill Mix-Up
Azurity Pharmaceuticals issued a recall for attention-deficit/hyperactivity disorder (ADHD) medication dextroamphetamine sulfate (Zenzedi) following the discovery of a potential mix-up in pill packaging,
Medicare Sees Surge in ACOs, but Challenges Remain
A record-breaking 13.4 million Medicare beneficiaries are now under the care of 122 accountable care organizations (ACOs) in the Realizing Equity, Access, and Community Health (REACH) Model and 481 ACOs in the Medicare Shared Savings Program,
Supreme Court to Review Mifepristone Restrictions
The US Supreme Court has announced its schedule to review a crucial case regarding mifepristone, a drug used in medication abortions, with arguments slated for late March,
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.